IMMP
Price
$1.72
Change
+$0.02 (+1.18%)
Updated
Jul 3 closing price
Capitalization
234.55M
51 days until earnings call
PHAR
Price
$10.24
Change
-$0.34 (-3.21%)
Updated
Jul 7, 10:30 AM (EDT)
Capitalization
719.3M
24 days until earnings call
Interact to see
Advertisement

IMMP vs PHAR

Header iconIMMP vs PHAR Comparison
Open Charts IMMP vs PHARBanner chart's image
Immutep
Price$1.72
Change+$0.02 (+1.18%)
Volume$16.5K
Capitalization234.55M
Pharming Group
Price$10.24
Change-$0.34 (-3.21%)
VolumeN/A
Capitalization719.3M
IMMP vs PHAR Comparison Chart in %
Loading...
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMMP vs. PHAR commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMP is a Hold and PHAR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (IMMP: $1.72 vs. PHAR: $10.58)
Brand notoriety: IMMP and PHAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMP: 5% vs. PHAR: 9%
Market capitalization -- IMMP: $234.55M vs. PHAR: $719.3M
IMMP [@Biotechnology] is valued at $234.55M. PHAR’s [@Biotechnology] market capitalization is $719.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMP’s FA Score shows that 0 FA rating(s) are green whilePHAR’s FA Score has 1 green FA rating(s).

  • IMMP’s FA Score: 0 green, 5 red.
  • PHAR’s FA Score: 1 green, 4 red.
According to our system of comparison, PHAR is a better buy in the long-term than IMMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMP’s TA Score shows that 5 TA indicator(s) are bullish while PHAR’s TA Score has 3 bullish TA indicator(s).

  • IMMP’s TA Score: 5 bullish, 5 bearish.
  • PHAR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IMMP is a better buy in the short-term than PHAR.

Price Growth

IMMP (@Biotechnology) experienced а +5.52% price change this week, while PHAR (@Biotechnology) price change was -2.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.35%. For the same industry, the average monthly price growth was +13.82%, and the average quarterly price growth was -0.82%.

Reported Earning Dates

IMMP is expected to report earnings on Aug 27, 2025.

PHAR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAR($719M) has a higher market cap than IMMP($235M). PHAR YTD gains are higher at: 5.117 vs. IMMP (-20.737). PHAR has higher annual earnings (EBITDA): 21.4M vs. IMMP (-43.83M). IMMP has more cash in the bank: 159M vs. PHAR (107M). IMMP has less debt than PHAR: IMMP (1.69M) vs PHAR (119M). PHAR has higher revenues than IMMP: PHAR (321M) vs IMMP (0).
IMMPPHARIMMP / PHAR
Capitalization235M719M33%
EBITDA-43.83M21.4M-205%
Gain YTD-20.7375.117-405%
P/E RatioN/AN/A-
Revenue0321M-
Total Cash159M107M149%
Total Debt1.69M119M1%
FUNDAMENTALS RATINGS
IMMP: Fundamental Ratings
IMMP
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMMPPHAR
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
76%
Momentum
ODDS (%)
Bullish Trend 5 days ago
87%
Bearish Trend 5 days ago
84%
MACD
ODDS (%)
Bullish Trend 5 days ago
84%
Bearish Trend 5 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 5 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 5 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 11 days ago
67%
Declines
ODDS (%)
Bearish Trend 18 days ago
82%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
80%
Bearish Trend 5 days ago
83%
Aroon
ODDS (%)
Bearish Trend 5 days ago
80%
Bullish Trend 5 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DMCFX29.630.34
+1.16%
Invesco Discovery Mid Cap Growth R5
STSCX40.630.29
+0.72%
Sterling Capital SmCp Val Instl
IBNYX24.970.13
+0.52%
Macquarie Balanced Fund Class Y
HLPPX10.190.05
+0.49%
LDR Real Estate Value Opportunity P
VCSOX27.840.04
+0.14%
VALIC Company I Intl Sclly Rspnb

IMMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMP has been loosely correlated with PRRUF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMP jumps, then PRRUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
+1.18%
PRRUF - IMMP
40%
Loosely correlated
N/A
YECO - IMMP
37%
Loosely correlated
N/A
BCRX - IMMP
32%
Poorly correlated
-0.89%
CGEN - IMMP
30%
Poorly correlated
+1.15%
BSFAF - IMMP
29%
Poorly correlated
N/A
More

PHAR and

Correlation & Price change

A.I.dvisor tells us that PHAR and IBRX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHAR and IBRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAR
1D Price
Change %
PHAR100%
-0.66%
IBRX - PHAR
27%
Poorly correlated
+3.03%
IMMP - PHAR
24%
Poorly correlated
+1.18%
VERU - PHAR
22%
Poorly correlated
+3.94%
CTXR - PHAR
22%
Poorly correlated
+5.24%
MGTX - PHAR
22%
Poorly correlated
+8.53%
More